3 reasons why an accurate bladder cancer diagnosis matters - UT MD Anderson
3 reasons why an accurate bladder cancer diagnosis matters UT MD Anderson
Bladder Cancer News
Bladder cancer 6th most prevalent among U.S. men and until now, there hasn't much advancement in treatment - Audacy
Bladder cancer 6th most prevalent among U.S. men and until now, there hasn't much advancement in treatment Audacy
Skin, Nerve, and Eye Side Effects of Metastatic Bladder Cancer Treatment - Everyday Health
Skin, Nerve, and Eye Side Effects of Metastatic Bladder Cancer Treatment Everyday Health
Early Intravesical Pirarubicin Improves Relapse-Free Survival in Upper Tract Urothelial Carcinoma - The ASCO Post
Early Intravesical Pirarubicin Improves Relapse-Free Survival in Upper Tract Urothelial Carcinoma The ASCO Post
CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances - AJMC
CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances AJMC
NDA Is Submitted for UGN-103 for Recurrent Low-Grade Intermediate-Risk NMIBC - OncLive
NDA Is Submitted for UGN-103 for Recurrent Low-Grade Intermediate-Risk NMIBC OncLive
FDA receives NDA submission for UGN-103 in recurrent LG-IR-NMIBC - Urology Times
FDA receives NDA submission for UGN-103 in recurrent LG-IR-NMIBC Urology Times
10 Must-Read Posts In GU Oncology This Week - Oncodaily
10 Must-Read Posts In GU Oncology This Week Oncodaily
Arkansas urologist explains treatment options for non-muscle invasive bladder cancer - KATV
Arkansas urologist explains treatment options for non-muscle invasive bladder cancer KATV
New Combination Therapy Shows Promise for Advanced Bladder Cancer - University of Colorado Anschutz
New Combination Therapy Shows Promise for Advanced Bladder Cancer University of Colorado Anschutz
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery - Mayo Clinic News Network
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery Mayo Clinic News Network
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms - Memorial Sloan Kettering Cancer Center
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms Memorial Sloan Kettering Cancer Center
Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II - Yahoo Finance
Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II Yahoo Finance
Ninety-nine patients entered a bladder cancer trial—what came next? - stocktitan.net
Ninety-nine patients entered a bladder cancer trial—what came next? stocktitan.net
Cretostimogene Grenadenorepvec in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer - The ASCO Post
Cretostimogene Grenadenorepvec in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer The ASCO Post
A new sensor could enable earlier detection of bladder cancer - MIT News
A new sensor could enable earlier detection of bladder cancer MIT News
Key Bladder Cancer Trials to Watch in 2026 - Oncology News Central
Key Bladder Cancer Trials to Watch in 2026 Oncology News Central
UroGen submits FDA application for bladder cancer drug UGN-103 By Investing.com - Investing.com UK
UroGen submits FDA application for bladder cancer drug UGN-103 By Investing.com Investing.com UK
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer - ASCO Publications
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer ASCO Publications
Can You Drink Alcohol With Metastatic Bladder Cancer? - Everyday Health
Can You Drink Alcohol With Metastatic Bladder Cancer? Everyday Health
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy - UT MD Anderson
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy UT MD Anderson
New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer - Mount Sinai
New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer Mount Sinai
Intravenous or Subcutaneous Atezolizumab for Bladder Cancer After Surgery - American Association for Cancer Research (AACR)
Intravenous or Subcutaneous Atezolizumab for Bladder Cancer After Surgery American Association for Cancer Research (AACR)
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. - AstraZeneca
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. AstraZeneca
Tommy John Cause of Death: What We Know About the MLB Legend's Illness Before His Death at 83 - Men's Journal
Tommy John Cause of Death: What We Know About the MLB Legend's Illness Before His Death at 83 Men's Journal
Bladder Cancer: What You Need to Know to Detect It Early - Dana-Farber Cancer Institute
Bladder Cancer: What You Need to Know to Detect It Early Dana-Farber Cancer Institute
Business People - Northwest Arkansas Democrat-Gazette
Business People Northwest Arkansas Democrat-Gazette
FDA Approves Perioperative Pembro Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer - Oncology News Central
FDA Approves Perioperative Pembro Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer Oncology News Central
Genitourinary Drugs Market to reach USD 38.29 Billion by 2035 at 1.72% CAGR - EIN News
Genitourinary Drugs Market to reach USD 38.29 Billion by 2035 at 1.72% CAGR EIN News
A Urine Test That Could Change the Course of Bladder Cancer Care - Stanford Medicine
A Urine Test That Could Change the Course of Bladder Cancer Care Stanford Medicine
Algae Microrobots Battle Bladder Cancer - the-scientist.com
Algae Microrobots Battle Bladder Cancer the-scientist.com
Bladder Cancer Treatment Is Changing: What Patients Should Know - Cure Today
Bladder Cancer Treatment Is Changing: What Patients Should Know Cure Today
Beyond the diagnosis: What living with bladder cancer really looks like - Johnson & Johnson
Beyond the diagnosis: What living with bladder cancer really looks like Johnson & Johnson
Immune Biomarkers May Predict Response to Bladder Cancer Treatment - Northwestern University
Immune Biomarkers May Predict Response to Bladder Cancer Treatment Northwestern University
WVU Cancer Institute expands bladder cancer treatment options for patients across region - WVU Medicine
WVU Cancer Institute expands bladder cancer treatment options for patients across region WVU Medicine
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery - Fox Chase Cancer Center
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery Fox Chase Cancer Center
Case-Control Analyses Explore Associations Between Environmental Exposures and Bladder Cancer - Cleveland Clinic
Case-Control Analyses Explore Associations Between Environmental Exposures and Bladder Cancer Cleveland Clinic
ASCO 2026: Discussant – Curing Early Bladder Cancer with Multidisciplinary Approaches - UroToday
ASCO 2026: Discussant – Curing Early Bladder Cancer with Multidisciplinary Approaches UroToday
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms - ASCO Publications
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms ASCO Publications
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial - AstraZeneca
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial AstraZeneca